Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus.

Assem NM, Mohammed AI, Barry HMA, El Sayed IET, Elmadbouh I

DOI: 10.1186/s43066-022-00231-x
Published: 2022
Container: Egyptian liver journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s43066-022-00231-x,
  title = {Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus.},
  author = {Assem NM and Mohammed AI and Barry HMA and El Sayed IET and Elmadbouh I},
  year = {2022},
  journal = {Egyptian liver journal},
  doi = {10.1186/s43066-022-00231-x},
  url = {https://doi.org/10.1186/s43066-022-00231-x}
}

RIS

TY  - JOUR
TI  - Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus.
AU  - Assem NM
AU  - Mohammed AI
AU  - Barry HMA
AU  - El Sayed IET
AU  - Elmadbouh I
PY  - 2022
JO  - Egyptian liver journal
DO  - 10.1186/s43066-022-00231-x
UR  - https://doi.org/10.1186/s43066-022-00231-x
ER  -

APA

NM, A., AI, M., HMA, B., IET, E. S., & I, E. (2022). Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus.. Egyptian liver journal. https://doi.org/10.1186/s43066-022-00231-x

Source records

pubmed · retrieved 2026-09-26T17:17:43.408Z